Rafael Holdings, Inc. (RFL): Total Assets
$83.06M
As of 2026-07-31
-5.6%
3-year compound annual growth
-11.6%
5-year compound annual growth
| Period ended | Total Assets | Change YoY | Source filing |
|---|---|---|---|
| 2026-07-31 | $83.06M | -27.2% | 2026-10-29, Balance as of period end |
| 2025-07-31 | $114.11M | +17.8% | 2026-10-29, Balance as of period end |
| 2024-07-31 | $96.83M | -2.0% | 2025-10-29, Balance as of period end |
| 2023-07-31 | $98.83M | -16.5% | 2024-12-20, Balance as of period end |
| 2022-07-31 | $118.32M | -23.2% | 2023-10-30, Balance as of period end |
| 2021-07-31 | $154.06M | +13.0% | 2022-10-31, Balance as of period end |
| 2020-07-31 | $136.35M | -4.1% | 2021-10-18, Balance as of period end |
| 2019-07-31 | $142.14M | +21.6% | 2020-10-29, Balance as of period end |
| 2018-07-31 | $116.92M | +35.6% | 2019-10-04, Balance as of period end |
| 2017-07-31 | $86.20M | n/a | 2018-10-15, Balance as of period end |
Total Assets at similar companies
| Company | Year ended | Total Assets | Change YoY |
|---|---|---|---|
| Rafael Holdings, Inc. (RFL) | 2026-07-31 | $83.06M | -27.2% |
| Rallybio Corp (RLYB) | 2025-12-31 | $62.26M | -8.6% |
| Onconetix, Inc. (ONCO) | 2025-12-31 | $24.93M | -11.5% |
| Shattuck Labs, Inc. (STTK) | 2025-12-31 | $91.03M | 0.0% |
| 60 Degrees Pharmaceuticals, Inc. (SXTP) | 2025-12-31 | $5.37M | -6.8% |
| Dare Bioscience, Inc. (DARE) | 2025-12-31 | $32.47M | +46.9% |
| Lexaria Bioscience Corp. (LEXX) | 2025-08-31 | $4.18M | -52.9% |
| China SXT Pharmaceuticals, Inc. (SXTC) | 2026-03-31 | $34.75M | +60.4% |
| Neuphoria Therapeutics Inc. (NEUP) | 2026-06-30 | $28.71M | +0.4% |
Compare RFL, RLYB, ONCO, STTK side by side · Screen every company in Pharmaceutical Preparations ↗